| scholarly article | Q13442814 |
| P2093 | author name string | Wiedemann B | |
| Nies BA | |||
| Meyer JF | |||
| Kliebe C | |||
| Tolxdorff-Neutzling RM | |||
| P2860 | cites work | Protein measurement with the Folin phenol reagent | Q20900776 |
| Emergence of Resistance to Cefamandole: Possible Role of Cefoxitin-Inducible Beta-Lactamases | Q24597685 | ||
| The pUC plasmids, an M13mp7-derived system for insertion mutagenesis and sequencing with synthetic universal primers | Q28131744 | ||
| Construction and characterization of amplifiable multicopy DNA cloning vehicles derived from the P15A cryptic miniplasmid | Q29614535 | ||
| Pedigrees of some mutant strains of Escherichia coli K-12 | Q33851231 | ||
| Directed selective pressure on a beta-lactamase to analyse molecular changes involved in development of enzyme function | Q34326192 | ||
| Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens | Q34708485 | ||
| R factor-mediated and chromosomal resistance to ampicillin in Escherichia coli | Q34898601 | ||
| Role of beta-lactam hydrolysis in the mechanism of resistance of a beta-lactamase-constitutive Enterobacter cloacae strain to expanded-spectrum beta-lactams | Q35570728 | ||
| Beta-Lactamase Stability of HR 756, a Novel Cephalosporin, Compared to That of Cefuroxime and Cefoxitin | Q39626868 | ||
| Molecular nature of a streptomycin and sulfonamide resistance plasmid (pBP1) prevalent in clinical Escherichia coli strains and integration of an ampicillin resistance transposon (TnA) | Q39854674 | ||
| Immunological properties of beta-lactamases that hydrolyze cefuroxime and cefotaxime | Q39855626 | ||
| Amikacin resistance mediated by multiresistance transposon Tn2424 | Q39976526 | ||
| Types of beta-lactamase determined by plasmids in gram-negative bacteria | Q39977677 | ||
| Molecular Specificities of R Factor-Determined Beta-Lactamases: Correlation with Plasmid Compatibility | Q40094131 | ||
| Properties of a R factor which originated in Pseudomonas aeruginosa 1822. | Q40098788 | ||
| Purification and properties of a new beta-lactamase from Pseudomonas cepacia | Q40281601 | ||
| Microiodometric Determination of β-Lactamase Activity | Q41027300 | ||
| Chromosomal beta-lactamases of Enterobacter cloacae are responsible for resistance to third-generation cephalosporins | Q41956941 | ||
| Kinetic study of 2 beta lactamases responsible for the same phenotype | Q54275106 | ||
| Purification and characterization of a cephalosporinase from E. coli | Q71484915 | ||
| Purification and properties of chromosomally mediated beta-lactamase from Citrobacter freundii GN7391 | Q72093276 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 302-307 | |
| P577 | publication date | 1985-08-01 | |
| P1433 | published in | Antimicrobial Agents and Chemotherapy | Q578004 |
| P1476 | title | Evolution of plasmid-coded resistance to broad-spectrum cephalosporins | |
| P478 | volume | 28 |
| Q46688453 | A 2-year trend of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Thailand: an alert for infection control |
| Q28076260 | A Review of SHV Extended-Spectrum β-Lactamases: Neglected Yet Ubiquitous |
| Q24677460 | A functional classification scheme for beta-lactamases and its correlation with molecular structure |
| Q33980082 | A novel CTX-M beta-lactamase (CTX-M-8) in cefotaxime-resistant Enterobacteriaceae isolated in Brazil |
| Q48878455 | A novel SHV-type beta-lactamase variant (SHV-89) in clinical isolates in China |
| Q33594236 | A novel class A extended-spectrum beta-lactamase (BES-1) in Serratia marcescens isolated in Brazil |
| Q42161441 | A retrospective view of beta-lactamases |
| Q35252077 | Activity of sulbactam in combination with ceftriaxone in vitro and in experimental endocarditis caused by Escherichia coli producing SHV-2-like beta-lactamase |
| Q37037740 | An epidemic of plasmids? Dissemination of extended-spectrum cephalosporinases among Salmonella and other Enterobacteriaceae |
| Q71670644 | An outbreak of multiply-resistant Klebsiella pneumoniae in the Grampian region of Scotland |
| Q37970720 | Are pleuromutilin antibiotics finally fit for human use? |
| Q39472406 | Automated thermal cycling is superior to traditional methods for nucleotide sequencing of bla(SHV) genes. |
| Q71950311 | Beta-lactam stability in frozen microdilution PASCO MIC panels using strains with known resistance mechanisms as biosensors |
| Q37756180 | Beta-lactamases identified in clinical isolates of Pseudomonas aeruginosa |
| Q53851440 | CTX-M: changing the face of ESBLs in the UK. |
| Q33690855 | Ceftazidime-resistant Enterobacteriaceae isolates from three Polish hospitals: identification of three novel TEM- and SHV-5-type extended-spectrum beta-lactamases |
| Q40410184 | Characterisation of extended-spectrum β-lactamase and AmpC β-lactamase-producing Enterobacteriaceae isolated from companion animals in New Zealand |
| Q38471723 | Characterization of a large outbreak by CTX-M-1-producing Klebsiella pneumoniae and mechanisms leading to in vivo carbapenem resistance development |
| Q54425163 | Characterization of extended-spectrum beta-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli from Posadas, Misiones, Argentina. |
| Q39814786 | Chromosomal beta-lactamase of Klebsiella oxytoca, a new class A enzyme that hydrolyzes broad-spectrum beta-lactam antibiotics |
| Q50919721 | Clinical impact and risk factors for colonization with extended-spectrum β-lactamase-producing bacteria in the intensive care unit. |
| Q34821049 | Clinical isolates of Enterobacteriaceae producing extended-spectrum beta-lactamases: prevalence of CTX-M-3 at a hospital in China |
| Q39816617 | Cloning of SHV-2, OHIO-1, and OXA-6 beta-lactamases and cloning and sequencing of SHV-1 beta-lactamase |
| Q40285545 | Comparative activities of clavulanic acid, sulbactam, and tazobactam against clinically important beta-lactamases |
| Q37083119 | Comparison of Antimicrobial Resistance in Escherichia coli Strains Isolated From Healthy Poultry and Swine Farm Workers Using Antibiotics in Korea |
| Q40014335 | Comparison of screening methods for detection of extended-spectrum beta-lactamases and their prevalence among blood isolates of Escherichia coli and Klebsiella spp. in a Belgian teaching hospital. |
| Q28361278 | Complete amino acid sequence of p453-plasmid-mediated PIT-2 beta-lactamase (SHV-1) |
| Q33469945 | Conjugative IncFI plasmids carrying CTX-M-15 among Escherichia coli ESBL producing isolates at a University hospital in Germany |
| Q33980763 | Contribution of natural amino acid substitutions in SHV extended-spectrum beta-lactamases to resistance against various beta-lactams |
| Q80940392 | Control of Enterobacteriaceae producing extended-spectrum beta-lactamase in intensive care units: rectal screening may not be needed in non-epidemic situations |
| Q51709834 | Detection and molecular genetics of extended-spectrum beta-lactamases among cefuroxime-resistant Escherichia coli and Klebsiella spp. isolates from Finland, 2002-2004. |
| Q54353073 | Detection of extended broad-spectrum beta-lactamases in Enterobacteriaceae in four French hospitals. |
| Q36536705 | Detection of extended-spectrum beta-lactamase (ESBL)-producing strains by the Etest ESBL screen. |
| Q42799124 | Detection of extended-spectrum beta-lactamases among Enterobacteriaceae by use of semiautomated microbiology systems and manual detection procedures |
| Q54589161 | Detection of genes coding for extended-spectrum SHV beta-lactamases in clinical isolates by a molecular genetic method, and comparison with the E test. |
| Q35291064 | Detection of plasmid-mediated beta-lactamases with DNA probes |
| Q35662482 | Detection of the SHV genotype polymorphism of the extended-spectrum β-lactamase-producing Gram-negative bacterium |
| Q34132715 | Development of "oligotyping" for characterization and molecular epidemiology of TEM beta-lactamases in members of the family Enterobacteriaceae |
| Q37958558 | Development of immunization trials against Klebsiella pneumoniae. |
| Q35111391 | Development of test panel of beta-lactamases expressed in a common Escherichia coli host background for evaluation of new beta-lactam antibiotics |
| Q40284915 | Different ratios of the piperacillin-tazobactam combination for treatment of experimental meningitis due to Klebsiella pneumoniae producing the TEM-3 extended-spectrum beta-lactamase |
| Q36165192 | Direct involvement of IS26 in an antibiotic resistance operon |
| Q39817170 | Discrimination of extended-spectrum beta-lactamases by a novel nitrocefin competition assay |
| Q43990645 | Dissemination in five French hospitals of Klebsiella pneumoniae serotype K25 harbouring a new transferable enzymatic resistance to third generation cephalosporins and aztreonam |
| Q39817435 | Dissemination of the novel plasmid-mediated beta-lactamase CTX-1, which confers resistance to broad-spectrum cephalosporins, and its inhibition by beta-lactamase inhibitors |
| Q35101453 | ESBLs: A Clear and Present Danger? |
| Q39174098 | EXTENDED-SPECTRUM BETA-LACTAMASE PRODUCING GRAM NEGATIVE BACTERIA IN IRAN: A REVIEW. |
| Q58124128 | Early-Onset Neonatal Sepsis with Extended Spectrum Beta-Lactamase Producing in Infants Born to South and South East Asian Immigrants: A Case Series |
| Q38392086 | Emerging issues in antimicrobial resistance of bacteria from food-producing animals |
| Q59386977 | Epidemiological typing of extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolates by pulsed-field gel electrophoresis and antibiotic susceptibility patterns |
| Q38018625 | Epidemiology and genetics of CTX-M extended-spectrum β-lactamases in Gram-negative bacteria |
| Q39353873 | Epidemiology of extended spectrum beta-lactamases |
| Q39697608 | Epidemiology of extended-spectrum beta-lactamase-producing Enterobacter isolates in a Spanish hospital during a 12-year period |
| Q89899478 | Epidemiology of β-Lactamase-Producing Pathogens |
| Q35653084 | Evidence for multiple forms of type I chromosomal beta-lactamase in Pseudomonas aeruginosa |
| Q33746844 | Evolution and spread of SHV extended-spectrum beta-lactamases in gram-negative bacteria |
| Q64924682 | Extended-spectrum Beta-lactamase-producing Escherichia coli Meningitis That Developed from Otitis Media with Cholesteatoma. |
| Q54439037 | Extended-spectrum beta-lactamase-producing Escherichia coli isolated in the Al-Amiri Hospital in 2003 and compared with isolates from the Farwania hospital outbreak in 1994-96 in Kuwait. |
| Q69547842 | Extended-spectrum beta-lactamases |
| Q35823228 | Extended-spectrum beta-lactamases in clinical isolates of Enterobacter gergoviae and Escherichia coli in China |
| Q43155418 | Extended-spectrum beta-lactamases in enterobacteria other than Escherichia coli and Klebsiella |
| Q24550671 | Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat |
| Q35558473 | Extended-spectrum β-lactamases: implications for the clinical microbiology laboratory, therapy, and infection control |
| Q35264577 | Failure of ceftazidime-amikacin therapy for bacteremia and meningitis due to Klebsiella pneumoniae producing an extended-spectrum beta-lactamase |
| Q35564179 | Frequency of in vitro resistance of Pseudomonas aeruginosa to cefepime, ceftazidime, and cefotaxime |
| Q36003062 | Genetic methods for detection of antimicrobial resistance |
| Q46021241 | Gly-238-Ser substitution changes the substrate specificity of the SHV class A beta-lactamases. |
| Q35006613 | Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes |
| Q39935716 | Identification of amino acid substitutions that alter the substrate specificity of TEM-1 beta-lactamase |
| Q45199586 | Impact of Mutations at Arg220 and Thr237 in PER-2 β-Lactamase on Conformation, Activity, and Susceptibility to Inhibitors. |
| Q36884104 | Influence of third-generation cephalosporin utilization on the occurrence of ESBL-positive Klebsiella pneumoniae strains. |
| Q39919691 | Integrated detection of extended-spectrum-beta-lactam resistance by DNA microarray-based genotyping of TEM, SHV, and CTX-M genes |
| Q44233614 | Investigation of extended-spectrum beta-lactamase in Klebsiellae pneumoniae and Escherichia coli from China |
| Q71502800 | Is it important to identify extended-spectrum beta-lactamase-producing isolates? |
| Q38001333 | Klebsiella pneumoniae carbapenemases in Enterobacteriaceae: history, evolution, and microbiology concerns |
| Q34633616 | Low rates of antimicrobial-resistant Enterobacteriaceae in wildlife in Taï National Park, Côte d'Ivoire, surrounded by villages with high prevalence of multiresistant ESBL-producing Escherichia coli in people and domestic animals |
| Q39685326 | Mechanisms of resistance to cephalosporin antibiotics |
| Q54291818 | Molecular Cloning and Nucleotide Sequence of a New Plasmid-Coded Klebsiella pneumoniae α-Lactamase Gene (SHV-2a) Responsible for High-Level Cefotaxime Resistance |
| Q34675362 | Molecular characterization of multidrug-resistant extended-spectrum β-lactamase-producing Enterobacteriaceae isolated in Antananarivo, Madagascar |
| Q39820453 | Molecular characterization of the gene encoding SHV-3 beta-lactamase responsible for transferable cefotaxime resistance in clinical isolates of Klebsiella pneumoniae |
| Q35248163 | Molecular epidemiology of TEM-3 (CTX-1) beta-lactamase |
| Q39555592 | Molecular epidemiology of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolates in a district hospital in Taiwan |
| Q40174075 | Molecular epidemiology of plasmid spread among extended broad-spectrum beta-lactamase-producing Klebsiella pneumoniae isolates in a pediatric hospital. |
| Q33915635 | Molecular mechanisms that confer antibacterial drug resistance |
| Q37520309 | More extended-spectrum beta-lactamases |
| Q64234402 | Multicentre randomised controlled trial to investigate usefulness of the rapid diagnostic βLACTA test performed directly on bacterial cell pellets from respiratory, urinary or blood samples for the early de-escalation of carbapenems in septic intens |
| Q38328297 | Mutations altering substrate specificity in OHIO-1, and SHV-1 family beta-lactamase |
| Q35117085 | New system based on site-directed mutagenesis for highly accurate comparison of resistance levels conferred by SHV beta-lactamases |
| Q39043364 | Nosocomial outbreak of acute gastroenteritis in a neonatal intensive care unit in tunisia caused by multiply drug resistantSalmonella wien producing SHV-2 beta-lactamase |
| Q54404338 | Novel R-factor borne beta-lactamase of Escherichia coli confering resistance to cephalosporins. |
| Q33802668 | Novel SHV-derived extended-spectrum beta-lactamase, SHV-57, that confers resistance to ceftazidime but not cefazolin |
| Q36433362 | Novel and emerging mechanisms of antimicrobial resistance in nosocomial pathogens |
| Q24674937 | Novel plasmid-mediated beta-lactamase (MIR-1) conferring resistance to oxyimino- and alpha-methoxy beta-lactams in clinical isolates of Klebsiella pneumoniae |
| Q39818693 | Novel plasmid-mediated beta-lactamase from Escherichia coli that inactivates oxyimino-cephalosporins |
| Q35302880 | Novel plasmid-mediated beta-lactamase in clinical isolates of Klebsiella pneumoniae more resistant to ceftazidime than to other broad-spectrum cephalosporins |
| Q35272574 | Nucleotide sequence and phylogeny of SHV-2 beta-lactamase |
| Q35565429 | Nucleotide sequence of SHV-2 beta-lactamase gene |
| Q35286957 | Nucleotide sequence of the SHV-5 beta-lactamase gene of a Klebsiella pneumoniae plasmid |
| Q40522673 | Nucleotide sequence of the gene encoding the SHV-2 beta-lactamase (blaSHV-2) of Klebsiella ozaenae |
| Q39817853 | Oligonucleotide probes (TEM-1, OXA-1) versus isoelectric focusing in beta-lactamase characterization of 114 resistant strains |
| Q40569192 | Origin and impact of plasmid-mediated extended-spectrum beta-lactamases |
| Q54641932 | Origin of transferable cefotaxime resistance in a clinical isolate of Escherichia coli by mutation. |
| Q54313107 | Outbreak of nosocomial infections due to Klebsiella pneumoniae producing SHV-4 beta-lactamase. |
| Q90645349 | Past and Present Perspectives on β-Lactamases |
| Q24676380 | Patterns and mechanisms of beta-lactam resistance among isolates of Escherichia coli from hospitals in the United States |
| Q35344839 | Pefloxacin versus ceftazidime in the treatment of a variety of gram-negative-bacterial infections |
| Q36809395 | Phenotypic and Molecular Assessment of Drug Resistance Profile and Genetic Diversity of Waterborne Escherichia coli |
| Q44383107 | Phenotypic and genotypic characterizations of Chinese strains of Escherichia coli producing extended-spectrum beta-lactamases |
| Q35333991 | Plasmid-mediated beta-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli resistant to ceftazidime |
| Q37155715 | Prevalence of Antibiotic Resistance in Escherichia coli Fecal Isolates From Healthy Persons and Patients With Diarrhea |
| Q36752663 | Properties of plasmids responsible for production of extended-spectrum beta-lactamases |
| Q41915492 | Pyrosequencing using the single-nucleotide polymorphism protocol for rapid determination of TEM- and SHV-type extended-spectrum beta-lactamases in clinical isolates and identification of the novel beta-lactamase genes blaSHV-48, blaSHV-105, and blaT |
| Q61810284 | Rapid Detection of Extended-Spectrum β-Lactamases (ESBL) and AmpC β-Lactamases in : Development of a Screening Panel Using the MALDI-TOF MS-Based Direct-on-Target Microdroplet Growth Assay |
| Q41830172 | Rates of fecal transmission of extended-spectrum β-lactamase-producing and carbapenem-resistant Enterobacteriaceae among patients in intensive care units in Korea |
| Q33982263 | Real-time PCR and melting curve analysis for reliable and rapid detection of SHV extended-spectrum beta-lactamases |
| Q36017993 | Resistance to broad-spectrum antibiotics in aquatic systems: anthropogenic activities modulate the dissemination of bla(CTX-M)-like genes. |
| Q38740369 | Resistance to third generation cephalosporins: the current situation |
| Q35563877 | Resistance to ticarcillin-potassium clavulanate among clinical isolates of the family Enterobacteriaceae: role of PSE-1 beta-lactamase and high levels of TEM-1 and SHV-1 and problems with false susceptibility in disk diffusion tests |
| Q33876254 | Review of Antibiotic Resistance in the Indian Ocean Commission: A Human and Animal Health Issue |
| Q40284079 | SHV-5, a novel SHV-type beta-lactamase that hydrolyzes broad-spectrum cephalosporins and monobactams |
| Q35113486 | SHV-7, a novel cefotaxime-hydrolyzing beta-lactamase, identified in Escherichia coli isolates from hospitalized nursing home patients |
| Q89745499 | Should we leave the paper currency? A microbiological examination |
| Q36433259 | Single amino acid substitution between SHV-1 beta-lactamase and cefotaxime-hydrolyzing SHV-2 enzyme |
| Q35364989 | Structural features related to hydrolytic activity against ceftazidime of plasmid-mediated SHV-type CAZ-5 beta-lactamase |
| Q40845510 | Study of beta-lactam resistance in ceftazidime-resistant clinical isolates of Enterobacteriaceae |
| Q35135773 | Survey and molecular genetics of SHV beta-lactamases in Enterobacteriaceae in Switzerland: two novel enzymes, SHV-11 and SHV-12. |
| Q33960781 | Survey of extended-spectrum beta-lactamases in clinical isolates of Escherichia coli and Klebsiella pneumoniae: prevalence of TEM-52 in Korea |
| Q34384513 | Synergy of Nitric Oxide and Silver Sulfadiazine against Gram-Negative, Gram-Positive, and Antibiotic-Resistant Pathogens |
| Q35360336 | TEM-4, a new plasmid-mediated beta-lactamase that hydrolyzes broad-spectrum cephalosporins in a clinical isolate of Escherichia coli |
| Q38842620 | Tackling Threats and Future Problems of Multidrug-Resistant Bacteria |
| Q43220935 | The Bla2 beta-lactamase from the live-vaccine strain of Francisella tularensis encodes a functional protein that is only active against penicillin-class beta-lactam antibiotics |
| Q60920666 | The Genetic Structures of an Extensively Drug Resistant (XDR) and Its Plasmids |
| Q38497797 | The complex epidemiology of extended-spectrum β-lactamase-producing Enterobacteriaceae |
| Q40196563 | The ecology of extended-spectrum β-lactamases (ESBLs) in the developed world |
| Q54193876 | Three beta-lactamases isolated from Aeromonas salmonicida, including a carbapenemase not detectable by conventional methods. |
| Q54181987 | Transferable Resistance to Cefotaxime in NosocomialKlebsiella pneumoniaeandEscherichia coliStrains Due to Their Production of Extended-Spectrum Beta-Lactamase in Slovakia |
| Q43665731 | Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae |
| Q38776963 | Travel-acquired ESBL-producing Enterobacteriaceae: impact of colonization at individual and community level |
| Q30354148 | Trends in human fecal carriage of extended-spectrum β-lactamases in the community: toward the globalization of CTX-M. |
| Q34077105 | Unexpected enzyme TEM-126: role of mutation Asp179Glu |
| Q36641669 | Use of ribotyping in epidemiological surveillance of nosocomial outbreaks |
| Q30491327 | Why the extended-spectrum beta-lactamases SHV-2 and SHV-5 are "hypersusceptible" to mechanism-based inhibitors |
| Q54306181 | [Evaluation of the development of resistance as a factor for the limitation of therapeutic possibilities]. |
| Q53990602 | [Spread of Enterobacteriaceae producing broad-spectrum beta-lactamase and the development of their incidence over a 16-month period in a university hospital center] |
| Q24669605 | beta-Lactamases in laboratory and clinical resistance |
| Q37035803 | β-Lactamase production in key gram-negative pathogen isolates from the Arabian Peninsula |
| Q38365280 | β-lactam and β-lactamase inhibitor combinations in the treatment of extended-spectrum β-lactamase producing Enterobacteriaceae: time for a reappraisal in the era of few antibiotic options? |
Search more.